TLR4 and obesity due to melanocortin 4 receptor deficiency: The study found that lowering TLR4 levels may improve obesity and insulin resistance in patients with type 2 diabetes, and targeted inhibition of TLR4 may be a potential target for the treatment of type 2 diabetes and its chronic complications [17,18,19].